| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA1614114 | Functional | PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line GB4. (Class of assay: confirmatory) | 742 | ALA1201862 | assay format | PubChem BioAssays | ||
| 2. | ALA1614171 | Functional | PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Human Peripheral Myelin Protein 22 (PMP22) Expression/Activity. (Class of assay: confirmatory) | Homo sapiens | 696 | ALA1201862 | assay format | PubChem BioAssays | |
| 3. | ALA1614236 | Functional | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) | Influenza A virus (A/WSN/1933(H1N1)) | 32,268 | ALA1201862 | assay format | PubChem BioAssays | |
| 4. | ALA1614458 | Functional | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | Homo sapiens | 75,376 | ALA1201862 | assay format | PubChem BioAssays | |
| 5. | ALA1614530 | Functional | PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))] | Escherichia coli | 61,607 | ALA1201862 | assay format | PubChem BioAssays | |
| 6. | ALA1614544 | Functional | PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) | Homo sapiens | 36,150 | ALA1201862 | assay format | PubChem BioAssays | |
| 7. | ALA1614433 | Functional | PUBCHEM_BIOASSAY: Counterscreen for APE1 Inhibitors: qHTS Validation Assay for Inhibitors of Endonuclease IV. (Class of assay: confirmatory) [Related pubchem assays: 1705, 1707 ] | Escherichia coli | 423 | ALA1201862 | assay format | PubChem BioAssays | |
| 8. | ALA1613767 | Functional | PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line W2. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1877 (Assay for Plasmodium falciparum line D10), 1816 (Assay for Plasmodium falciparum line GB4), 1876 (Assay for Plasmodium falciparum line 7D3), 1828 (Summary assay)] | 881 | ALA1201862 | assay format | PubChem BioAssays | ||
| 9. | ALA1614019 | Functional | PUBCHEM_BIOASSAY: qHTS Assay for Lipid Storage Modulators. (Class of assay: confirmatory) | Drosophila | 2,097 | ALA1201862 | assay format | PubChem BioAssays | |
| 10. | ALA806320 | Functional | Anthelmintic activity (in Vivo)in sheep as percentage reduction versus control (by administration of benzimidazole-susceptible L3 larvae of Haemonchus contortus intraruminally)at 7.5 mg/kg po | Ovis aries | 1 | ALA1125904 | organism-based format | Scientific Literature | |
| 11. | ALA807789 | Functional | Anthelmintic activity (in Vivo)in sheep as percentage reduction versus control (by administration of benzimidazole-susceptible L3 larvae of Ostertagia circumcincta intraruminally)at 7.5 mg/kg po | Ovis aries | 1 | ALA1125904 | organism-based format | Scientific Literature | |
| 12. | ALA809635 | Functional | Anthelmintic activity (in Vivo)in sheep as percentage reduction versus control (by administration of benzimidazole-susceptible L3 larvae of Trichostrongylus colubriformis intraruminally) at 7.5 mg/kg po | Ovis aries | 1 | ALA1125904 | organism-based format | Scientific Literature | |
| 13. | ALA1266185 | Functional | Inhibition of neurosphere proliferation of mouse neural precursor cells by MTT assay | Mus musculus | 1,252 | ALA1255231 | assay format | Scientific Literature | |
| 14. | ALA1267249 | Functional | Antiplasmodial activity against Plasmodium falciparum GB4 after 72 hrs by SYBR green assay | Plasmodium falciparum | 567 | ALA1255382 | organism-based format | Scientific Literature | |
| 15. | ALA1794375 | Binding | PUBCHEM_BIOASSAY: qHTS for inhibitors of binding or entry into cells for Marburg Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249, AID540278] | 83,389 | ALA1201862 | assay format | PubChem BioAssays | ||
| 16. | ALA1794345 | Functional | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | Plasmodium falciparum | 170,142 | ALA1201862 | organism-based format | PubChem BioAssays | |
| 17. | ALA1794573 | Functional | PUBCHEM_BIOASSAY: qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity. (Class of assay: confirmatory) | 661 | ALA1201862 | assay format | PubChem BioAssays | ||
| 18. | ALA1794580 | Functional | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | Plasmodium falciparum | 130,890 | ALA1201862 | organism-based format | PubChem BioAssays | |
| 19. | ALA3252339 | Functional | Antitrypanosomal activity against Trypanosoma cruzi infected in albino CF1 mouse assessed as reduction in number of parasites in blood at 104 mg/kg/day, intramuscular treatment started on day 10 of infection up to day 14 | Trypanosoma cruzi | 22 | ALA3244238 | organism-based format | Scientific Literature | |
| 20. | ALA3252340 | Functional | Antitrypanosomal activity against Trypanosoma cruzi infected in albino CF1 mouse assessed as reduction in number of parasites in blood at 52 mg/kg/day, intramuscular treatment started on day 10 of infection up to day 14 | Trypanosoma cruzi | 20 | ALA3244238 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!